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Mammalian genomes contain many unknown alternative ﬁrst exons and promoters. Thus, we have
modiﬁed the existing 50 RACE (50 rapid ampliﬁcation of cDNA ends) approach into a next-generation
sequencing (NGS)-based new protocol that can identify these alternative promoters. This protocol has
incorporated two main ideas: (i) 50 RACE starting from the known second exons of genes and (ii) NGSbased sequencing of the subsequent cDNA products. This protocol also provides a bioinformatics strategy that processes the sequence reads from NGS runs. This protocol has successfully identiﬁed several
alternative promoters for an imprinted gene, PEG3. Overall, this NGS-based 50 RACE protocol is a sensitive
and reliable method for detecting low-abundant transcripts and promoters.
© 2015 Elsevier Inc. All rights reserved.
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In eukaryotic cells, gene transcription is regulated through
several cis-regulatory DNA elements such as promoters, enhancers,
silencers, and insulators [1]. Identifying promoters is one of the
initial steps for characterizing transcriptional regulation for any
given gene. In model organisms, the promoters of the majority of
genes have been identiﬁed through large-scale sequencing efforts
[2]. According to recent results, however, transcripts are quite often
detected from the upstream regions of many genes that are outside
of the previously deﬁned transcribed regions. This indicates that
additional transcription start sites and alternative promoters may
exist for many genes [3]. In the current study, thus, we have
modiﬁed and adapted the existing 50 RACE (50 rapid ampliﬁcation of
cDNA ends)1 [4] approach into a next-generation sequencing
(NGS)-based new protocol that can identify the alternative promoters for these transcripts. The main strength of this new protocol
is its sensitivity; this can detect the 50 ends of mRNA that are of very
low abundance. The main ideas and detailed steps for this protocol
are described below.
Two main ideas have been incorporated into this new protocol.
First, the initial cDNA for 50 RACE needs to be prepared with the
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reverse transcription (RT) reaction using gene-speciﬁc oligonucleotide primers (Fig. 1B). These gene-speciﬁc primers also need to be
derived from the known second exons, but not from the known ﬁrst
exons, for genes. The known ﬁrst exons are not a good choice
because these exons do not have splicing acceptor sites at their 50
ends. Instead, they have transcription start sites; thus, they cannot
be connected to any upstream exons. By contrast, the known second exons have proper splicing acceptor sites; thus, they should be
ideal regions for anchoring the upstream alternative exons that
have not been identiﬁed so far. Second, potential unknown alternative ﬁrst exons most likely represent the sequences that belong
to very low-abundant transcripts given all of the sequencing efforts
by the genomic community. Therefore, this new protocol uses NGSbased approaches to identify the sequences derived from these
very minor transcripts. NGS-based sequencing should allow the
identiﬁcation of these low-abundant transcripts given their
sequencing capacity (million reads per library). This new protocol,
therefore, includes several steps that can easily convert polymerase
chain reaction (PCR) products into NGS libraries.
The detailed steps for the new protocol are as follows (Fig. 1A;
see also Supplementary Material 1 in the online supplementary
material). In step 1, the total RNA isolated from tissue samples is
reverse-transcribed with gene-speciﬁc primers (dark arrow in
Fig. 1B). The subsequent cDNA needs to be puriﬁed through phenol/
chloroform extraction followed by ethanol precipitation. In step 2,
the cDNA is modiﬁed through the tailing reaction using deoxyguanosine triphosphate (dGTP) and terminal deoxynucleotidyl
transferase (TdT). In step 3, a pool of the G-tailed cDNA is targeted
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Fig.1. Overall scheme for the NGS-based 50 RACE protocol. A A ﬂow chart shows the entire procedure of the NGS-based 50 RACE protocol. B A schematic illustration represents the
genomic structure of a given locus, with its promoters and exons indicated by triangles and rectangles, respectively. The bent arrow indicates the transcriptional direction of the
gene. The previously known transcript and its alternative transcript are shown in black and light blue, respectively. The total RNA isolated from the desired tissue is ﬁrst reversetranscribed using gene-speciﬁc primers, as indicated by the black arrow underneath the exon structure. The resulting cDNA product is then puriﬁed and modiﬁed with the tailing
reaction using dGTP and TdT, as indicated by the extended blue and black arrows with a G mark. The cDNA is then used as a template for a nested PCR I with the following two
primers: an internal gene-speciﬁc primer (gray arrow) and a primer made of a unique sequence plus a C-tail (indicated by XC). The product from PCR I is subsequently used for PCR
II with another internal gene-speciﬁc primer (gray arrow) and the second primer speciﬁc for the unique sequence (arrow indicated by X). The resulting products are end-repaired
and ligated to barcoded adapters as shown by the green boxes. A set of several 50 RACE libraries can be pooled together for NGS-based sequencing. The sequences from NGS runs are
sorted based on the barcoded adapters and also the G-tailed and gene-speciﬁc primer portion of the cDNA products. These sorted sequences are further divided into individual
groups based on their different combinations of exon joining. These groups of the sorted sequences are analyzed to examine their exon structures using the UCSC genome browser.
Each group with a different exon joining can also be analyzed for the frequency (or representation) in a given library. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.).

and enriched for a given gene through a nested PCR scheme
involving two sets of primers: two gene-speciﬁc primers (gray arrows) and two primers targeting the G-tailed portion of cDNA (XC
and X; blue arrows). A small amount of PCR products from each PCR
needs to be separated on a 2% agarose gel to monitor the proper
ampliﬁcation of cDNA. In step 4, the ampliﬁed product from the
second PCR is modiﬁed with the end repair reaction and later with
the ligation reaction to be analyzed with NGS-based sequencing.
The current protocol has been tested multiple times using an NGS
platform (PGM2, Ion Torrent), which requires two speciﬁc sequences at either end of all the DNA fragments to be analyzed (A
and P adapters). Thus, the two adapters containing these sequences
need to be ligated onto either end of the cDNA. An NGS platform
usually allows the simultaneous sequencing of multiple libraries;
thus, several cDNA libraries derived from multiple tissues are also
ligated individually with a set of adapters with different barcodes.
In step 5, the pool of individual barcoded libraries is ampliﬁed with
PCR and subsequently sequenced using an NGS platform. In step 6,
the raw sequence reads from NGS runs are sorted ﬁrst by their
barcodes and later by the sequences of the two primers: X and the
gene-speciﬁc primer used for the second PCR of the nested scheme
(Fig. 1B). This sorting process can be executed through several Unix
command lines, which has been included as Supplementary Material 1. These ﬁltered reads are further processed to identify
alternative exons using a PERL script, which can detect and count
the number of raw reads that have different combinations of exon
joining with the initial exon (E2 in Fig. 1B). In step 7, each group of
the raw reads displaying different exon joining can be mapped to
the genome sequence of a given species using the UCSC (University
of California, Santa Cruz) genome browser, which will then identify
new alternative exons. This bioinformatics pipeline along with one
PERL script has been included as Supplementary Material 2.

The feasibility of this protocol has been tested through identifying alternative promoters for an imprinted gene called PEG3
(paternally expressed gene 3) (Fig. 2). This gene is composed of 9
exons that are spread throughout 25-kb genomic regions in both
human and mouse, and it is highly expressed in the brain [5e7].
Interestingly, the 200-kb upstream region of this gene is well
conserved among all of the mammals without any additional open
reading frames (ORFs); thus, this region has been suspected to
harbor other unknown cis-regulatory elements [8]. This new protocol, therefore, has been applied to test whether this region contains any unknown alternative promoters. First, the total RNA from
mouse and human brains was individually used for generating
50 RACE cDNA libraries, and later these libraries were sequenced
using an NGS platform. Each library derived on average several
hundred thousand reads, and these raw reads were further
analyzed with the bioinformatics strategy described previously.
According to the results, the majority of cDNA sequences were
indeed derived from the transcripts with the known exon combination (E1eE2): 93% for mouse and 74% for human PEG3 (Fig. 2B).
However, this protocol also detected some minor transcripts from
both mouse and human, and these transcripts were very low in
abundance based on their representations in the libraries: 0.33% for
mouse and 0.13% for human PEG3. Detailed inspection further
revealed that these minor transcripts skip the known ﬁrst exons but
are connected to previously unknown alternative exons (U1 in
Fig. 2A). It also revealed that the new U1 exons of PEG3 are not
conserved between mouse and human genomic regions. Individual
RTePCR analyses indeed conﬁrmed the presence of these minor
transcripts for mouse and human PEG3 (Fig. 2C). Until now, there
has never been any clue suggesting the presence of alternative
promoters for the PEG3 locus, although this locus has been intensively studied for more than two decades. Thus, this new protocol
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Fig.2. Alternative transcripts and promoters identiﬁed for mouse and human PEG3. A Genomic structure of PEG3. The black and blue boxes represent the 9 previously known exons
and the newly identiﬁed alternative exons of PEG3, respectively. The bent black arrow indicates the transcriptional direction of PEG3. The E1eE2 transcript contains the known ﬁrst
and second exons of PEG3. The mouse U1eE2 transcript harbors the newly identiﬁed alternative ﬁrst exon but skips the known ﬁrst exon of PEG3. The human U1eE2 transcript
starts from the newly identiﬁed alternative ﬁrst exon, which also skips the known ﬁrst exon of PEG3. B Relative frequency of alternative transcripts for mouse and human PEG3. The
table summarizes the relative representation (%) of the transcripts with E1 (known ﬁrst exons) and U1 (alternative ﬁrst exons) of PEG3. The relative representations (%) are
calculated through dividing the number of reads containing the E1, mU1 (mouse), and hU1 (human) exons by the total number of reads for each library. The total number of reads
for each library represents the sorted sequences that still contain both the G-tail and gene-speciﬁc primer portions at their 50 and 30 ends. C RTePCR analyses for alternative exons.
The E1eE2 primer combination targets the transcript containing the known ﬁrst and second exons of PEG3. The U1eE2 primer combination detects the transcript with the newly
found alternative ﬁrst exon connected to the second exon of PEG3. The top and bottom panels represent the RTePCR products from mouse and human brains, respectively. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)

appears to be very robust in identifying low-abundant transcripts
and corresponding alternative promoters.
This newly developed protocol, NGS-based 50 RACE, may be used
for other similar studies that intend to identify low-abundant
transcripts for their gene of interest based on the following reasons. First, this protocol is very sensitive; it can detect very lowabundant transcripts and corresponding alternative promoters. As
demonstrated above, this protocol successfully detected a minor
transcript that makes up only 0.1% of all transcripts from human
PEG3. This level of sensitivity cannot be achieved with the existing
50 RACE protocols. This protocol also provides clear exon structures
for a given locus, which is not always feasible with other NGS data,
such as RNA-seq, due to their relatively short read lengths. Second,
the new protocol can estimate the relative expression levels of the
alternative transcripts for a given locus among various tissues or
stages. The number of raw sequence reads belonging to each
transcript can be easily converted into its relative representation in
a given cDNA library, which can further indicate the strength of the
corresponding alternative promoter. This type of information could
be very important because the in vivo function of a given gene often
manifests through its tissue and stage-speciﬁc alternative promoters. Third, this protocol is reliable and reproducible. We have
tested more than 15 rounds of 50 RACE followed by NGS runs, and
each round was consistently successful for identifying new alternative exons and promoters. Despite these strengths, however, the
current protocol also has one caveat. We have been selecting DNA
fragments less than 400 bp in length for actual NGS runs due to the
read length limitation that can be afforded by current NGS platforms. Thus, any 50 RACE cDNA products greater than 400 bp in
length cannot be sequenced through the current protocol. Nevertheless, this NGS-based 50 RACE protocol appears to be a very sensitive and reliable method for identifying low-abundant alternative
transcripts and promoters.
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